Prescription drug · UNAPPROVED DRUG OTHER
Anusol HC (hydrocortisone acetate) NDC 65649-411
Hydrocortisone acetate 25 mg/1 · Suppository · Rectal · Salix Pharmaceuticals, Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 65649-411-12 | 65649041112 | 12 SUPPOSITORY in 1 BOX (65649-411-12)Marketed from Jun 1, 2004 | |
| 65649-411-24 | 65649041124 | 24 SUPPOSITORY in 1 BOX (65649-411-24)Marketed from Jun 1, 2004 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Anusol HC
- Generic name (nonproprietary)
- hydrocortisone acetate
- Active ingredients
- Hydrocortisone acetate — 25 mg/1
- Dosage form
- Suppository
- Route
- Rectal
- Labeler
- Salix Pharmaceuticals, Inc
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 65649-411_3bb1affd-e321-496d-8bec-0feb8cc15e51SPL ID 3bb1affd-e321-496d-8bec-0feb8cc15e51SPL set ID a562f3d7-2692-4357-aade-ae50afcbfdddRxCUI 1291082, 1291103UNII 3X7931PO74UPC 0365649411120
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N465649041112followed by a unit qualifier and the quantityPackage 65649-0411-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE For use in inflamed hemorrhoids, post-irradiation (factitial) proctitis, as an adjunct in the treatment of chronic ulcerative colitis, cryptitis, other inflammatory conditions of the anorectum, and pruritus ani.
Excerpt only. Read the full label for complete information.